Exelixis, Teva fight over Cabometyx generic again
Cancer-focused biotech Exelixis, Inc. (EXEL) has filed another court case against Israeli drugmaker Teva Pharmaceutical Industries (TEVA) on allegations of patent infringement related to…
Exelixis, Teva fight over Cabometyx generic again
Cancer-focused biotech Exelixis, Inc. (EXEL) has filed another court case against Israeli drugmaker Teva Pharmaceutical Industries (TEVA) on allegations of patent infringement related to…